Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study-Reference-Cited by-同舟云学术

Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study

Published:2023-10 Issue: Volume:64 Page:102249
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Liu Zhigang^ORCID,Alexander James L.^ORCID,Le Kaixing,Zhou Xin,Ibraheim Hajir,Anandabaskaran Sulak,Saifuddin Aamir,Lin Kathy Weitung,McFarlane Leon R.,Constable Laura,Seoane Rocio Castro,Anand Nikhil^ORCID,Bewshea Claire^ORCID,Nice Rachel,D'Mello Andrea,Jones Gareth R.,Balarajah Sharmili,Fiorentino Francesca,Sebastian Shaji,Irving Peter M.,Hicks Lucy C.,Williams Horace RT.,Kent Alexandra J.,Linger Rachel,Parkes Miles,Kok Klaartje,Patel Kamal V.,Teare Julian P.,Altmann Daniel M.,Boyton Rosemary J.,Hart Ailsa L.,Lees Charlie W.,Goodhand James R.,Kennedy Nicholas A.,Pollock Katrina M.,Ahmad Tariq,Powell Nick^ORCID,Chukwurah Ijeoma,Haq Sulaimaan,Lo Jonathan,Shah Parita,Wilken-Smith Stephanie,Ramanathan Anitha,Patel Mikin,Romanczuk Lidia,King Rebecca,Domingo Jason,Shamtally Djamila,Mendoza Vivien,Sanchez Joanne,Stark Hannah,Knight Bridget,Bee Louise,Estember Charmaine,Barnes Anna,Watkins Darcy,Stone Sam,Kirkwood John,Parkinson Marian,Gardner-Thorpe Helen,Covil Kate,Derikx Lauranne,Alcalde Beatriz Gros,Lee Irish,Cipriano Bessie,Ruocco Giuseppe,Baden Manisha,Cooke Graham,Kourampa Evgenia,Pasquale Ciro,Robisco-Diaz Elena,Bhatti Suhaylah

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

2. Public health impact of covid-19 vaccines in the US: observational study;Suthar;BMJ,2022

3. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar;Chemaitelly;Nat Med,2021

4. Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant;Bernal;New Engl J Med,2021

5. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study;Chung;BMJ,2021